952188-00-0,
N-[Ethyl-(2-pyridyl-5-ethyl) Pioglitazone(Pioglitazone Impurity),
(5RS)-5-((4-(2-(5-Ethylpyridin-2-yl)ethoxy)phenyl)methyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione,
N-(Ethyl-(2-pyridyl-5-ethyl)) pioglitazone,
(5RS)-5-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione,
Pioglitazone Impurity C,
Pioglitazone Impurity E,
Pioglitazone hydrochloride specified impurity C [EP],
SCHEMBL4181113,
CTK8E7570,
PIOGLITAZONE EP IMPURITY C,
Pioglitazone hydrochloride impurity, N-alkylpioglitazone- [USP],
AKOS030255511,
(+/-)-5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione,
2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-3-(2-(5-ethyl-2-pyridinyl)ethyl)-,
RT-014603,
FT-0668388,
(5RS)-5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione,
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-3-[2-(5-ethyl-2-pyridinyl)ethyl]-2,4-thiazolidinedione,
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione,
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-3-[2-(5-ethyl-2-pyridyl)ethyl]thiazolidine-2,4-dione,
Pioglitazone Impurity,
UNII-0A40W8CWPF,
(Pioglitazone Impurity)",
0A40W8CWPF,
4-[2- ethoxy]benzenepropanoicAcidEthylEster,
868754-42-1,
5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione,